Psychiatric Comorbidities in 1p36 Deletion Syndrome and Their Treatment—A Case Report
Open Access
- 17 November 2021
- journal article
- case report
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (22) , 12064
Abstract
1p36 deletion syndrome represents the most common terminal deletion observed in humans. Major clinical findings comprise developmental delay/intellectual disability, poor or absent expressive language, congenital central muscular hypotonia, brain anomalies, brachydactyly/camptodactyly, short feet, and characteristic facial features like straight eyebrows, deep-set eyes, and midface hypoplasia. So far, there is very limited knowledge about comorbid psychiatric disorders and their effective treatment in this special population. To fill this gap, this case report presents an initially four-year-old girl with 1p36.33–1p36.32 deletion, moderate intellectual disability, insomnia, oppositional-defiant disorder and attention deficit/hyperactivity disorder covering a period of time of about 1.5 years comprising initial psychological/psychiatric assessment, subsequent day clinic/outpatient treatment (amongst others including off-label use of melatonin and methylphenidate as well as parent-child interaction therapy) and follow-up assessment. Follow-up results indicated good efficacy of melatonin and methylphenidate medication without any adverse effects. Multidisciplinarity in diagnosis and treatment are mandatory to meet needs of patients with complex genetic disorders like 1p36 deletion syndrome. Off-label use of melatonin (for insomnia) and methylphenidate (for attention deficit/hyperactivity disorder) should be considered in young children with 1p36 deletion syndrome if behavioral interventions are not sufficient.Keywords
This publication has 51 references indexed in Scilit:
- Prevalence of Chronic Health Conditions in Children With Intellectual Disability: A Systematic Literature ReviewIntellectual and Developmental Disabilities, 2011
- The German Version of the Satisfaction With Life Scale (SWLS)European Journal of Psychological Assessment, 2011
- Recurrent interstitial 1p36 deletions: Evidence for germline mosaicism and complex rearrangement breakpointsAmerican Journal of Medical Genetics Part A, 2010
- Linkage to Chromosome 1p36 for Attention-Deficit/Hyperactivity Disorder Traits in School and Home SettingsBiological Psychiatry, 2008
- Self-injurious behaviour in individuals with intellectual disabilitiesCurrent Opinion in Psychiatry, 2005
- Physical Map of 1p36, Placement of Breakpoints in Monosomy 1p36, and Clinical Characterization of the SyndromeThe American Journal of Human Genetics, 2003
- Der Verlauf psychischer Störungen vom Kindes- zum ErwachsenenalterZeitschrift für Klinische Psychologie und Psychotherapie, 2000
- Factors affecting the risk of behaviour problems in children with severe intellectual disabilityJournal of Intellectual Disability Research, 2000
- Methods for defining and determining the clinical significance of treatment effects: Description, application, and alternatives.Journal of Consulting and Clinical Psychology, 1999
- Parent-Child Interaction Therapy:Child & Family Behavior Therapy, 1988